CoChat

Matrix-bound nanovesicles within ECM bioscaffolds

Open access

The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.

Abstract

Matrix-bound vesicles within ECM bioscaffolds provide mechanistic insight into inductive properties.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1126/sciadv.1600502

Cites

69 of 69 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Comparison of nucleic acid concentration from UBM, SIS, or dermis and their commercially available equivalents. (A to C) Concentration of total nucleic acid and dsDNA per milligram dry weight of ECM scaffold from untreated (control) and proteinase K– or collagenase-treated samples of (A) UBM and ACell MatriStem (porcine UBM), (B) SIS and Cook Biotech Biodesign (porcine SIS), and (C) dermis and C.R. Bard XenMatrix (porcine dermis). Total nucleic acid concentration was assessed by UV absorbance at 260 nm. dsDNA concentration was assessed using PicoGreen dsDNA quantification reagent. Variability from isolation to isolation is depicted by SD. Data are means ± SD; n = 3 isolations per sample.
Fig. 1 Comparison of nucleic acid concentration from UBM, SIS, or dermis and their commercially available equivalents. (A to C) Concentration of total nucleic acid and dsDNA per milligram dry weight of ECM scaffold from untreated (control) and proteinase K– or collagenase-treated samples of (A) UBM and ACell MatriStem (porcine UBM), (B) SIS and Cook Biotech Biodesign (porcine SIS), and (C) dermis and C.R. Bard XenMatrix (porcine dermis). Total nucleic acid concentration was assessed by UV absorbance at 260 nm. dsDNA concentration was assessed using PicoGreen dsDNA quantification reagent. Variability from isolation to isolation is depicted by SD. Data are means ± SD; n = 3 isolations per sample.CC BY-NC · PubMed Central
Fig. 2 Enzymatic digestion of decellularized ECM scaffolds releases small RNA molecules. (A) Nucleic acid extracted from untreated UBM (no digest) and pepsin-, proteinase K–, or collagenase-treated UBM was exposed to RNase A, DNase I, or no-nuclease treatment (control). (B) Electropherogram depicting the small RNA pattern of nucleic acid in fluorescence units (FU) before (top panel) and after (bottom panel) DNase I treatment. (C) Electropherogram depicting small RNA pattern from the indicated samples in FU. (D) A subset of nucleic molecules in biologic scaffolds is protected from nuclease degradation.
Fig. 2 Enzymatic digestion of decellularized ECM scaffolds releases small RNA molecules. (A) Nucleic acid extracted from untreated UBM (no digest) and pepsin-, proteinase K–, or collagenase-treated UBM was exposed to RNase A, DNase I, or no-nuclease treatment (control). (B) Electropherogram depicting the small RNA pattern of nucleic acid in fluorescence units (FU) before (top panel) and after (bottom panel) DNase I treatment. (C) Electropherogram depicting small RNA pattern from the indicated samples in FU. (D) A subset of nucleic molecules in biologic scaffolds is protected from nuclease degradation.CC BY-NC · PubMed Central
Fig. 3 Identification of ECM-embedded MBVs. (A) TEM imaging of MBVs identified in a UBM sheet stained positive with osmium (left panel), pepsin-treated UBM (middle panel), or proteinase K–treated UBM (right panel). (B) TEM imaging of MBVs identified in proteinase K–treated ECM from three commercial and three laboratory-produced scaffolds. Scale bars, 100 nm. (C) Validation of MBV size was measured with NanoSight. (D) Western blot analysis was performed on four exosomal surface markers: CD63, CD81, CD9, and Hsp70. Expression levels were not detectable as compared to porcine serum, human serum, and human bone marrow–derived mesenchymal stem cell controls. (E) MBV protein cargo signature was different between MBVs and hMSCs as evaluated using SDS-PAGE and silver stain imaging.
Fig. 3 Identification of ECM-embedded MBVs. (A) TEM imaging of MBVs identified in a UBM sheet stained positive with osmium (left panel), pepsin-treated UBM (middle panel), or proteinase K–treated UBM (right panel). (B) TEM imaging of MBVs identified in proteinase K–treated ECM from three commercial and three laboratory-produced scaffolds. Scale bars, 100 nm. (C) Validation of MBV size was measured with NanoSight. (D) Western blot analysis was performed on four exosomal surface markers: CD63, CD81, CD9, and Hsp70. Expression levels were not detectable as compared to porcine serum, human serum, and human bone marrow–derived mesenchymal stem cell controls. (E) MBV protein cargo signature was different between MBVs and hMSCs as evaluated using SDS-PAGE and silver stain imaging.CC BY-NC · PubMed Central
Fig. 4 Identification of miRNA packaged within MBVs. MBV small RNA sequencing analysis reveals specific miRNA signature between commercial products and comparable in-house products (n = 1). (A) Numbers in each box represents different miRNAs within each sample. (B and C) Molecular and cellular functions (B) and physiological system development and function pathways (C) associated with identified miRNAs were generated using IPA. Each box represents the numbers of different miRNAs involved in each pathway.
Fig. 4 Identification of miRNA packaged within MBVs. MBV small RNA sequencing analysis reveals specific miRNA signature between commercial products and comparable in-house products (n = 1). (A) Numbers in each box represents different miRNAs within each sample. (B and C) Molecular and cellular functions (B) and physiological system development and function pathways (C) associated with identified miRNAs were generated using IPA. Each box represents the numbers of different miRNAs involved in each pathway.CC BY-NC · PubMed Central
Fig. 5 MBVs are biologically active. MBVs isolated from UBM were labeled with Exo-Glow. (A) C2C12 cells were exposed to labeled MBVs for 4 hours. The left panel shows a representative image of successful labeling of MBVs before exposure to cell culture. The right panel represents exposure of labeled MBVs in C2C12 compared to the middle panel image (control). Green fluorescence represents DNA, whereas red fluorescence represents RNA MBV cargo that is successfully integrated with target cells. (B) Bone marrow was isolated from C57bl/6 mice and cultured in medium supplemented with macrophage colony-stimulating factor (M-CSF) to derive macrophages. Macrophages were treated with IFN-γ (20 ng/ml) and LPS (100 ng/ml) to derive M1 macrophages, IL-4 (20 ng/ml) to derive M2 macrophages, and isolated MBVs (5 μg/ml) from a UBM source. Macrophages were fixed and immunolabeled for the pan-macrophage marker (F4/80) and markers associated with the M1 (iNOS) and M2 (Fizz-1) phenotype. MBV-treated macrophages are predominantly F4/80 + Fizz-1 + macrophages, indicating an M2-like phenotype. Experiment was conducted with n = 2 samples with four technical replicates. (C) N1E-115 neuroblastoma cells were exposed to pepsin-solubilized UBM and MBVs. Five days (solubilized UBM) and three days (MBVs) after exposure, neurite extensions were visible in treated cells compared to control.
Fig. 5 MBVs are biologically active. MBVs isolated from UBM were labeled with Exo-Glow. (A) C2C12 cells were exposed to labeled MBVs for 4 hours. The left panel shows a representative image of successful labeling of MBVs before exposure to cell culture. The right panel represents exposure of labeled MBVs in C2C12 compared to the middle panel image (control). Green fluorescence represents DNA, whereas red fluorescence represents RNA MBV cargo that is successfully integrated with target cells. (B) Bone marrow was isolated from C57bl/6 mice and cultured in medium supplemented with macrophage colony-stimulating factor (M-CSF) to derive macrophages. Macrophages were treated with IFN-γ (20 ng/ml) and LPS (100 ng/ml) to derive M1 macrophages, IL-4 (20 ng/ml) to derive M2 macrophages, and isolated MBVs (5 μg/ml) from a UBM source. Macrophages were fixed and immunolabeled for the pan-macrophage marker (F4/80) and markers associated with the M1 (iNOS) and M2 (Fizz-1) phenotype. MBV-treated macrophages are predominantly F4/80 + Fizz-1 + macrophages, indicating an M2-like phenotype. Experiment was conducted with n = 2 samples with four technical replicates. (C) N1E-115 neuroblastoma cells were exposed to pepsin-solubilized UBM and MBVs. Five days (solubilized UBM) and three days (MBVs) after exposure, neurite extensions were visible in treated cells compared to control.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 387

Metadata

Authors
Huleihel, L., Hussey, G. S., Naranjo, J. D., Zhang, L., Dziki, J. L., Turner, N. J., Stolz, D. B., & Badylak, S. F.
Affiliations
University of Pittsburgh (US)
Corresponding author
Badylak, Stephen F.
Venue
Science Advances
Published
2016-06-03
Volume
2
Issue
6
Pages
e1600502-e1600502
ISSN
2375-2548 (ISSN-L)
OpenAlex
W2417862864
Cited by
387
References
69
Citations by year
2026: 28 · 2025: 47 · 2024: 58 · 2023: 46 · 2022: 50 · 2021: 41 · 2020: 37 · 2019: 26 · 2018: 26 · 2017: 26 · 2016: 2
FWCI
13.85
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • Science Advances (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
  • Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
  • Physical Sciences › Materials Science › Biomaterials › Electrospun Nanofibers in Biomedical Applications
Keywords
extracellular vesicles, microRNA, macrophage activation, neuroblastoma cell differentiation, tissue engineering, scaffold degradation, intercellular communication, angiogenesis, stem cell recruitment, tissue homeostasis
MeSH terms
Extracellular Vesicles, Animals, Biocompatible Materials, DNA, Extracellular Matrix, Macrophages, Nucleic Acids, Swine, Tissue Engineering, Regenerative Medicine, Nanostructures, Mice, Tissue Scaffolds

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.